Generate Chart For |
|
|
(Chart displayed below) |
Rat Strains
{{sample.term}}
|
Measurement Methods
{{method.term}}
|
|
|
48 | mammary tumor number | SPRD/Ztm | female | 11.23 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11340 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
20 | mammary tumor number | COP/OlaHsd | female | 0.4 | | 17 beta-estradiol (27.5 mg) (between 212 and 330 days) | 11753 | 17 beta-estradiol (27.5 mg) (between 212 and 330 days) | | |
34 | mammary tumor number | ACI/SegHsd | female | 3.9 | | 17 beta-estradiol (27.5 mg) (between 144 and 195 days) | 11752 | 17 beta-estradiol (27.5 mg) (between 144 and 195 days) | | |
17 | mammary tumor number | WKY/NHsd | female | 0 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11741 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
21 | mammary tumor number | WF/NHsd | female | 7.3 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11742 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
50 | mammary tumor number | WF/NHsd | female | 6.9 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11743 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
13 | mammary tumor number | WF.WKY-(D5Wox7-D5Uwm37)/Uwm | female | 1.1 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11744 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
29 | mammary tumor number | WF.WKY-(D5Rat26-D5Uwm42)/Uwm | female | 5.7 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11745 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
30 | mammary tumor number | WF/NHsd | female | 8.1 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11746 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
16 | mammary tumor number | COP/OlaHsd | female | 0.25 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11747 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
14 | mammary tumor number | SS-Chr 19BN/Mcwi | female | 8.79 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 11507 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
13 | mammary tumor number | SS-Chr 16BN/Mcwi | female | 6.31 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 11504 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
13 | mammary tumor number | SS-Chr 13BN/Mcwi | female | 5.33 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 11501 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
22 | mammary tumor number | ACI/SegHsd | female | 8.8 | | 17 beta-estradiol (27.5 mg) (between 193 and 199 days) | 11382 | 17 beta-estradiol (27.5 mg) (between 193 and 199 days) | | |
13 | mammary tumor number | BN/SsNHsd | female | 0 | | 17 beta-estradiol (27.5 mg) (between 196 and 199 days) | 11381 | 17 beta-estradiol (27.5 mg) (between 196 and 199 days) | | |
20 | mammary tumor number | ACI/SegHsd | female | 5.6 | | 17 beta-estradiol (27.5 mg) (between 99 and 197 days) | 11377 | 17 beta-estradiol (27.5 mg) (between 99 and 197 days) | | |
7 | mammary tumor number | COP/CrCrl | female | 0.1 | | 17 beta-estradiol (27.5 mg) (for 196 days) | 11370 | 17 beta-estradiol (27.5 mg) (for 196 days) | | |
40 | mammary tumor number | SS/JrHsdMcwi | female | 2.45 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 11488 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
25 | mammary tumor number | SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm | female | 9.24 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | 11357 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | | |
46 | mammary tumor number | SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm | female | 7.61 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | 11356 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | | |
14 | mammary tumor number | SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm | female | 3.93 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | 11355 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | | |
17 | mammary tumor number | SPRD/Ztm | female | 10.89 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | 11354 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | | |
5 | mammary tumor number | COP/CrCrl | female | 0 | | control condition | 11369 | control condition | | |
21 | mammary tumor number | ACI/SegHsd | female | 7 | | 17 beta-estradiol (27.5 mg) (for 196 days) | 11368 | 17 beta-estradiol (27.5 mg) (for 196 days) | | |
4 | mammary tumor number | ACI/SegHsd | female | 0 | | control condition | 11367 | control condition | | |
12 | mammary tumor number | ACI.COP-(D10Mgh8-D10Rat4)/Shul | female | 4.8 | | 17 beta-estradiol (27.5 mg) (for 196 days) | 11366 | 17 beta-estradiol (27.5 mg) (for 196 days) | | |
3 | mammary tumor number | ACI.COP-(D10Mgh8-D10Rat4)/Shul | female | 0 | | control condition | 11365 | control condition | | |
17 | mammary tumor number | ACI.COP-(D3Rat130-D3Rat114)/Shul | female | 4.5 | | 17 beta-estradiol (27.5 mg) (for 196 days) | 11364 | 17 beta-estradiol (27.5 mg) (for 196 days) | | |
3 | mammary tumor number | ACI.COP-(D3Rat130-D3Rat114)/Shul | female | 0 | | control condition | 11363 | control condition | | |
8 | mammary tumor number | ACI.COP-(D3Mgh16-D3Rat119)/Shul | female | 4.3 | | 17 beta-estradiol (27.5 mg) (for 196 days) | 11362 | 17 beta-estradiol (27.5 mg) (for 196 days) | | |
3 | mammary tumor number | ACI.COP-(D3Mgh16-D3Rat119)/Shul | female | 0 | | control condition | 11361 | control condition | | |
17 | mammary tumor number | ACI.COP-(D6Rat80-D6Rat146)/Shul | female | 2.4 | | 17 beta-estradiol (27.5 mg) (for 196 days) | 11360 | 17 beta-estradiol (27.5 mg) (for 196 days) | | |
3 | mammary tumor number | ACI.COP-(D6Rat80-D6Rat146)/Shul | female | 0 | | control condition | 11359 | control condition | | |
33 | mammary tumor number | SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm | female | 5 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | 11358 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) | | |
46 | mammary tumor number | SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm | female | 7.61 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11342 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
14 | mammary tumor number | SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm | female | 3.93 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11341 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
14 | mammary tumor number | SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi | female | 4.86 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 65573 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
53 | mammary tumor number | WF | female | 3.62 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days) | 66100 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (between 126 and 140 days) | | |
14 | mammary tumor number | SS.BN-(D6Rat149-D6Arb3)/Mcwi | female | 4.77 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 65571 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
32 | mammary tumor number | WF.WKY-(D7Rat171-D7Rat128)/2Uwm | female | 3.9 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66061 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
17 | mammary tumor number | WF.WKY-(D7Rat171-D7Rat128)/1Uwm | female | 3.5 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66060 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
23 | mammary tumor number | WF.WKY-(D7Rat51-D7Rat128)/Uwm | female | 8 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66062 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
43 | mammary tumor number | WF.WKY-(D7Uwm25-D7Rat128)/Uwm | female | 7.2 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66063 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
28 | mammary tumor number | WF.WKY-(D7Rat171-D7Rat45)/Uwm | female | 3.4 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66064 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
16 | mammary tumor number | WF.COP-(D7Rat39-D7Uwm12)/1Uwm | female | 2.4 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66065 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
16 | mammary tumor number | WF.COP-(D7Rat39-D7Uwm12)/2Uwm | female | 2 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66066 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
19 | mammary tumor number | WF | female | 7.3 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 66067 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
29 | mammary tumor number | WF/NHsd | female | 6.3 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 70167 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
19 | mammary tumor number | WF.COP-(D2Mit29-D2Rat201)/Uwm | female | 1.5 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 70168 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
35 | mammary tumor number | WF.WKY-(D5Uwm67-D5Uwm98)/Uwm | female | 3.2 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70296 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
40 | mammary tumor number | WF.WKY-(D5Uwm76-D5Uwm61)/Uwm | female | 4.2 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70297 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
26 | mammary tumor number | WF.WKY-(D5Uwm76-D5Uwm98)/Uwm | female | 3.8 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70298 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
32 | mammary tumor number | WF.WKY-(D5Uwm67-D5Uwm78)/Uwm | female | 8.6 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70299 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
27 | mammary tumor number | WF.WKY-(D5Uwm76-D5Got18)/Uwm | female | 3.5 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70300 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
32 | mammary tumor number | WF.WKY-(D5Uwm78-D5Uwm98)/Uwm | female | 2.8 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70301 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
36 | mammary tumor number | WF.WKY-(D5Uwm95-D5Uwm98)/Uwm | female | 7.4 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70302 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
26 | mammary tumor number | WF.WKY-(D5Uwm67-D5Uwm81)/Uwm | female | 8.3 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70303 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
58 | mammary tumor number | WF.WKY-(D5Uwm76-D5Uwm92)/Uwm | female | 4.8 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70304 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
29 | mammary tumor number | WF.WKY-(D5Uwm78-D5Uwm84)/Uwm | female | 8.8 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70305 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
27 | mammary tumor number | WF.WKY-(D5Uwm78-D5Uwm93)/Uwm | female | 5 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70306 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
41 | mammary tumor number | WF.WKY-(D5Uwm78-D5Uwm84)/Uwm | female | 8.1 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70307 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
58 | mammary tumor number | WF.WKY-(D5Uwm88-D5Uwm92)/Uwm | female | 6.9 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70308 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
56 | mammary tumor number | WF.WKY-(D5Uwm87-D5Uwm92)/Uwm | female | 6.3 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70309 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
51 | mammary tumor number | WF.WKY-(D5Uwm85-D5Uwm92)/Uwm | female | 3.9 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70310 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
18 | mammary tumor number | WF.WKY-(D5Uwm82-D5Uwm92)/Uwm | female | 2.6 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70311 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
58 | mammary tumor number | WF.WKY-(D5Uwm82-D5Uwm91)/Uwm | female | 3.4 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70312 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
12 | mammary tumor number | WF.WKY-(D5Uwm77-D5Uwm91)/Uwm | female | 3.8 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70313 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
46 | mammary tumor number | WF/NHsd | female | 7.9 | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | 70314 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) | | |
32 | mammary tumor number | Crl:CD(SD) | female | 2.84 | | maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) | 76264 | maternal milk (for 20 days) | vehicle control condition (for 15 days) | 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) |
34 | mammary tumor number | Crl:CD(SD) | female | 3.82 | | maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) | 76265 | maternal milk (for 20 days) | bisphenol A (25 ug/kg) (for 15 days) | 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) |
24 | mammary tumor number | Crl:CD(SD) | female | 5 | | maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) | 76266 | maternal milk (for 20 days) | bisphenol A (250 ug/kg) (for 15 days) | 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) |